Horizon Technology Finance (HRZN)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NASDAQ
Market Cap: $223.41M
Last updated: Nov 17, 2026 at 4:39 PM ET
Horizon Technology Finance (HRZN) Statistics
Horizon Technology Finance (HRZN) has a market cap of $223.41M. Revenue grew 339.53% over the last 12 months from the 12 months before. Its share count is up 44.67% from a year earlier.
Total Valuation
| Market Cap | $223.41M |
|---|---|
| Latest price (Nov 17, 2026) | $3.22 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 16, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Next Ex-Dividend Date | Dec 16, 2026 |
| Next Payment Date | Jan 15, 2027 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.6x and 0.6x. Its year-end P/E ranged from 5.7x to 11.3x from 2016 to 2025.
| P/E Ratio | 4.3x |
|---|---|
| Forward P/E | 4.7x |
| P/S Ratio | 2.6x |
| Forward P/S | 2.3x |
| P/B Ratio | 0.6x |
| P/FCF Ratio | 2.0x |
| P/OCF Ratio | 2.1x |
Price Statistics
The stock is down 43.65% over 52 weeks and trades 24.06% below its 50-day average.
| Beta (1Y) | 1.00 |
|---|---|
| 52-Week Change | -43.65% |
| 1-Month Change | -21.65% |
| 3-Month Change | -34.00% |
| 6-Month Change | -13.40% |
| 5-Year Change | -76.68% |
| 10-Year Change | -68.45% |
| Total Return (1Y) | -26.84% |
| Total Return (3Y CAGR) | -25.97% |
| Total Return (5Y CAGR) | -18.69% |
| Return vs SPY (1Y) | -54.87% |
| Max Drawdown (1Y) | -47.38% |
| Max Drawdown (3Y) | -64.38% |
| Sharpe Ratio (1Y) | -1.24 |
| Correlation with SPY (1Y) | 0.30 |
| 50-Day Average | $4.24 |
| 200-Day Average | $4.34 |
| 52-Week Range | $3.33 to $5.80 |
| RSI (14 Days) | 19.6 |
| Average Volume (20 Days) | 545.53K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.51x current liabilities.
| Current Ratio | 1.51x |
|---|---|
| Quick Ratio | 1.51x |
| Interest Coverage | 3.58x |
Returns and Efficiency
Return on equity is -14.88% over the last 12 months, against a 5-year average of 2.03%.
| Return on Equity (ROE) | -14.88% |
|---|---|
| Return on Assets (ROA) | -6.92% |
| ROE (5Y Average) | 2.03% |
| ROA (5Y Average) | 1.00% |
| ROIC (5Y Average) | 9.62% |
| Asset Turnover | 0.11x |
| Receivables Turnover | 6.53x |
Scores
HRZN has an Altman Z-Score of -0.18, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -0.18 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $81.12M over the last 12 months.
| Revenue | $81.12M |
|---|---|
| Revenue Growth (YoY) | +339.53% |
| Gross Profit | $62.00M |
| Operating Income | $16.48M |
| Pretax Income | -$53.69M |
| Net Income | -$53.89M |
| Reported EPS (TTM) | $0.75 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 46.50% of the $778.73M in total assets.
| Cash and Equivalents | $105.17M |
|---|---|
| Working Capital | $40.73M |
| Shareholder Equity | $362.14M |
| Book Value Per Share | $5.46 |
| Total Assets | $778.73M |
| Total Liabilities | $416.59M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $0 of capital spending, operating cash flow left $107.11M of free cash flow.
| Operating Cash Flow | $107.11M |
|---|---|
| Capital Expenditures | $0 |
| Free Cash Flow | $107.11M |
| FCF Per Share | $1.64 |
| Depreciation and Amortization | $4.04M |
| Dividends Paid | $71.22M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 20.31%, against a 5-year average of 28.09%.
| Gross Margin | 76.43% |
|---|---|
| Operating Margin | 20.31% |
| Pretax Margin | -66.18% |
| Net Margin | -66.43% |
| FCF Margin | 132.04% |
| Gross Margin (5Y Average) | 34.26% |
| Operating Margin (5Y Average) | 28.09% |
| Net Margin (5Y Average) | 9.94% |
Growth
Revenue grew 14.53% a year over 3 years, and EPS fell 7.63% a year.
| Revenue Growth (3Y CAGR) | +14.53% |
|---|---|
| Revenue Growth (5Y CAGR) | +31.11% |
| EPS Growth (3Y CAGR) | -7.63% |
| EPS Growth (5Y CAGR) | -1.28% |
| Book Value Per Share Growth (2Y CAGR) | -12.03% |
| Tangible Book Per Share Growth (2Y CAGR) | -12.03% |
Dividends and Yields
| Dividend Per Share (Annual) | $1.08 |
|---|---|
| Dividend Yield | 33.54% |
| Dividend Growth (3Y CAGR) | +1.56% |
| Dividend Growth (5Y CAGR) | +1.10% |
| FCF Payout Ratio | 66.49% |
| Earnings Yield | 23.26% |
| FCF Yield | 50.16% |
| Shareholder Yield | 33.35% |
Peer Position
Against 9 similar companies, HRZN has the lowest P/E and the 7th highest P/S.
P/E RatioPeer median 5.5x
P/S RatioPeer median 4.1x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -29.61%
Dividend YieldPeer median 16.30%
| P/E Ratio | 4.3x vs 5.5x median |
|---|---|
| P/S Ratio | 2.6x vs 4.1x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +339.53% vs -29.61% median |
| Dividend Yield | 33.54% vs 16.30% median |
Analyst Forecast
Consensus estimates put revenue growth at 65.64% and EPS growth at -18.87% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +65.64% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -18.87% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HRZN
What is HRZN's market cap?
Horizon Technology Finance has a market cap of $223.41M.
What is HRZN's P/E ratio?
Horizon Technology Finance has a trailing P/E ratio of 4.3x and a forward P/E of 4.7x.
How many shares of HRZN are outstanding?
Horizon Technology Finance has 66.31M shares outstanding. The count is up 44.67% from a year earlier.
Does HRZN pay a dividend?
Yes. Horizon Technology Finance pays $1.08 a share a year, a dividend yield of 33.54%.
HRZN pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors